Biotech pioneer Amgen is joining the hunt to find new drugs to treat the novel coronavirus, making the company the latest drugmaker to shift resources to the pandemic. Amgen has partnered with Adaptive Biotechnologies, mobilizing the two companies to discover a treatment.
Amgen joins quest for R&D of coronavirus drug
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.